# A Study of Experimental Medication BMS-986235 in Healthy Subjects

> **NCT03335553** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 122 (actual)

## Conditions studied

- Mediators of Inflammation

## Interventions

- **DRUG:** BMS-986235
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03335553
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-15
- **Primary completion:** 2021-07-02
- **Final completion:** 2021-07-02
- **Target enrollment:** 122 (ACTUAL)
- **Last updated:** 2022-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03335553

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03335553, "A Study of Experimental Medication BMS-986235 in Healthy Subjects". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03335553. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*